RevvoMed Innovations is a Stockholm-based biotechnology company focused on early-stage drug discovery. The company identifies and characterizes drug target structures with the potential to enable more effective therapies with fewer side effects. RevvoMed translates its discoveries into intellectual property and commercial opportunities through patents, licensing agreements and partnerships with pharmaceutical and biotechnology companies.
